CIDRAP newsletters options
People age 35 to 49 have especially contributed to recent outbreaks.
Findings suggest the vaccine provides strong protection after 1 dose and could slow disease spread.
Though US numbers have fallen, the CDC head warns they are overall still very high.
CARB-X announced today that it is awarding up to $6.4 million to French biopharmaceutical firm Mutabilis to develop a new class of antibiotics to treat infections caused by carbapenem-resistant Enterobacterales (CRE) bacteria.
Higher viral loads of SARS-CoV-2, the virus that causes COVID-19, are associated with an increased risk of transmission, according to cohort study results from Catalonia, Spain, published yesterday in The Lancet Infectious Diseases,
"Another vaccine can now join the fight to reduce the incidence of COVID-19."
Researchers find some B117 variants with the E484K mutation tied to vaccine resistance, and data raise red flags about vaccine protection.
Also, vaccine doses sent to states will rise from 10 million to 10.5 million.
CDC researchers recommend improving racial data tracking and health workers' uptake.
An assessment of 90 Veterans Health Administration (VHA) hospitals found that carbapenem-specific stewardship strategies were associated with a lower volume of carbapenem use and more appropriate carbapenem prescribing, researchers reported yesterday in the Journal of Antimicrobial Chemotherapy.
Recovered COVID-19 patients given a single dose of a currently authorized mRNA vaccine had a robust immune response equal to or exceeding that reached by their coronavirus-naïve peers after the second dose, according to a non–peer reviewed study published yesterday on the medRxiv preprint server.
"The maximum public health benefit would come from giving a single dose to as many people as possible."
Israel and the UK are signaling they will keep precautions in place over the threat of new variant viruses.
One study finds county-level disparity; the other highlights ethnicity and community exposure in health workers.
Unemployment insurance was tied to a food insecurity reduction of 4.3 percentage points and a reduction in the need to eat less because of financial constraints of 5.7 percentage points during the COVID-19 pandemic, according to a JAMA Network Open study published late last week.
CARB-X announced today that it is awarding up to $2.5 million to Avails Medical of Menlo Park, California, to develop an electronic antibiotic susceptibility test (eAST).
The vaccine is 66% effective in preventing moderate to severe symptoms.
The report looks at medical supply chains, manufacturer transparency, financial aid, and more.
Antibodies crossed the placenta in 87% of pregnant women who had COVID-19.
Some nations, like Germany, have raised concerns about efficacy in seniors.
